Último video

Posición de los trocares para cirugía laparoscópica y robótica de riñón y pélvica de acuerdo a la anatomía

Ver todos los videos

Artículo de la semana

  • Tivozanib in renal cell carcinoma: a new approach to previously treated disease

    Targeted therapies have been a mainstay of the renal cell carcinoma (RCC) treatment paradigm for the better part of two decades. Multikinase inhibitors of the vascular endothelial growth factor receptor tyrosine kinases (VEGF-TKIs) comprise nearly all targeted therapies in RCC, having been prospectively tested through large, multi-institutional phase III trials. ...

Ver todos los artículos

Sobre nosotros

El L.A.R.C.G (Latin American renal Cancer Group) es un grupo de carácter científico y educativo, multicentrico, multidisciplinario e independiente. No tiene fines de lucro, y el plazo de funcionamiento es indeterminado. Esta constituido por Urólogos, Patólogos y Oncólogos, además de profesionales e investigadores relacionados al ámbito de la salud, pertenecientes a Hospitales de América Latina, España y Estados Unidos.

Leer más

Últimos Tweets

Just in @KCA_Journal 👉🏻1/3rd patients with mRCC kidneycancer have bone mets. Scant data on development, prevention, prognosis and treatment of skeletal related events (SREs) in mRCC👉🏻Excellent systemic review by @PBarataMD @bilenma & team. @KidneyCancer https://t.co/Q6FoU859BQ

3

Not typical for an #oncologist to sift through @NatRevNeph so leading my friends towards this DEFINITIVE article on #kidneycancer biomarkers written from start to finish by @NazliDizman, a resident now at @YaleMedicine. Please have a look! @neerajaiims @DrChoueiri @kamkalantar https://t.co/lj7XnQIAfF

Load More...

Sponsor

Asociados

You don't have permission to register